Gene Query: MRPL14

Dataset Description Geneva Score
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 26.45
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 26.45
Peptidomimetic blockade of MYB in acute myeloid leukemia 25.6
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 25.6
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 22.91
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 21.55
The comparison of high-throughput single-cell RNA-seq methods 19.55
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 19.45
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 18.47
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 16.87
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 16.23
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 15.82
HNF1A deficiency impairs β-cell fate, granule maturation and function 15.72
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 15.27
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 15.11
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 15.02
Global analysis of enhancer targets: Mosaic-seq 15.0
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 14.72
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 14.33
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 13.25
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 12.79
Gene expression profiling of leukemia cells following asparagine depletion 12.42
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 12.17
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 12.06
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 11.97
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 11.97
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 11.67
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 11.64
DART-seq: an antibody-free method for global m6A detection 11.6
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 11.55
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 11.48
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 11.44
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 11.41
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 11.12
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 11.11
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 11.11
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 11.07
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 11.06
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 11.0
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 10.87
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 10.87
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 10.8
CROP-Seq in Primary Human T Cells 10.78
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 10.68
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 10.56
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 10.33
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 10.12
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 10.12
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 10.11
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 10.08
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 10.08
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 9.88
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 9.85
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 9.85
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 9.8
The evolution of N6-methyladenosine in primates 9.72
Differetially expressed genes after hTR overexpression in U2OS cells 9.66
Cajal bodies are linked to genome conformation 9.6
Cajal bodies are linked to genome conformation [RNA-Seq] 9.6
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 9.47
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 9.36
NRDE2 negatively regulates nuclear exosome functions 9.24
Systematic discovery of endogenous human ribonucleoprotein complexes 9.11
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 8.77
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 8.75
Integrin signaling regulates YAP/TAZ to control skin homeostasis 8.59
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 8.47
Generating Patterned Kidney Organoids for Studying Development and Diseases 8.44
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 8.32
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 8.27
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 8.24
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 8.16
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 8.13
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 8.12
Identification of transcription start sites for human A549 cell line using ReCappable-seq 8.12
Human Treg IL-12 stimulation 8.05
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 7.91
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 7.82
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 7.81
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 7.6
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 7.58
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 7.49
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 7.44
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 7.43
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 7.42
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 7.41
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 7.38
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 7.3
Trans-differentiation of human adult peripheral blood T cells into neurons 7.26
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 7.25
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 7.25
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 7.21
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 7.17
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 7.16
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 7.14
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 7.12
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 7.12
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 7.08
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 6.97
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 6.84
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 6.84
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 6.84
Impact of dieldrin on transcription in Jurkat T cells 6.77
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 6.76
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 6.62
Regulation of protein translation during mitosis 6.61
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 6.6
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 6.49
Direct Isolation and Characterization of Human Nephron Progenitors. 6.46
Cleavage Factor Im as a key regulator of 3’ UTR length 6.45
Spliceosomal disruption of the non-canonical BAF complex in cancer 6.42
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 6.4
A transcriptome-wide divergence in protein translation scales with LIN28B expression 6.36
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 6.33
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 6.29
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 6.28
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 6.25
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 6.24
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 6.24
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 6.2
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 6.16
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 6.12
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 6.06
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 6.04
Inhibition of TNBC metastasis by Gpx1 6.04
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 6.01
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 6.01
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 6.0
Expression by CD133+ cells isolated from the adult human exocrine pancreas 6.0
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 5.94
Oncogenic roles of ARID5B in T-ALL 5.94
Transcriptional profiling of microglia; current state of the art and future perspectives 5.9
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 5.89
Genes significantly down or Up-regulated upon RNF219 knockdown 5.87
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 5.82
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 5.82
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 5.82
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 5.82
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 5.79
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 5.74
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 5.73
Identification of renal resident macrophages across species 5.72
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 5.69
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 5.67
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 5.65
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 5.62
hnRNP C is a key regulator of protein synthesis in mitosis 5.61
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 5.59
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 5.58
Transcriptome landscape of HeLa response upon triamcinolone acetonide 5.56
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 5.56
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 5.55
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 5.54
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 5.54
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 5.54
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 5.54
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 5.53
Identification of renal resident macrophages across species [C1] 5.33
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 5.32
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 5.24
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  5.22
Transcriptome sequencing of K-562 cells 5.22
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 5.22
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 5.21
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 5.17
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 5.17
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 5.16
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 5.15
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 5.15
Positively selected enhancer elements endow tumor cells with metastatic competence 5.13
Comprehensive comparative analysis of 5’ end RNA sequencing methods 5.13
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 5.13
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 5.13
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 5.09
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 5.08
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 5.08
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 5.05
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 5.03
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 5.03
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 5.02
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 5.02
snRNAs as regulators of alternative splicing 5.01
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 5.0
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 5.0
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 5.0
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 4.93
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 4.92
RNA-seq analysis of control and Myc-induced U2OS cells 4.92
RNA-seq of cells with TET1 knockout 4.92
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 4.89
Generation of KRAS signatures using immortalized isogenic lung cells. 4.88
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 4.84
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 4.84
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 4.83
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 4.74
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 4.73
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 4.71
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 4.69
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 4.68
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 4.67
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 4.67
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 4.66
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 4.66
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 4.66
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 4.66
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 4.6
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 4.59
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 4.55
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 4.55
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 4.52
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 4.51
RNA editing in nascent RNA affects pre-mRNA splicing 4.5
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 4.5
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 4.49
Single-cell analysis of human kidney organoids 4.46
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 4.42
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 4.39
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 4.39
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 4.38
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 4.36
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 4.36
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 4.34
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 4.34
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 4.31
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 4.31
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 4.29
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 4.27
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 4.27
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 4.26
Role of microRNAs in the interaction between Salmonella and the host cell 4.24
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 4.19
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 4.18
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 4.18
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 4.18
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 4.13
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 4.09
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 4.08
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 4.08
Transcriptome analysis of human lung epithelial cells 4.06
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 4.05
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 4.05
RNA sequencing of primary human platelets and in vitro cell lines 4.04
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 4.02
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 4.02
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 4.01
RNA-sequencing of healthy human skeletal myocytes 3.97
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 3.95
Seletive inhibition of CDK9 in DLBCL cell lines 3.91
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 3.9
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 3.88
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 3.88
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 3.87
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 3.85
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 3.85
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 3.85
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 3.84
miRNAs affected by antagomiR-17 treatment 3.81
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 3.79
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 3.78
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 3.78
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 3.74
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 3.73
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 3.71
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 3.69
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 3.66
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 3.65
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.64
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.64
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 3.6
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 3.57
Generation and persistence of human tissue-resident memory T cells in lung transplantation 3.55
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 3.55
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 3.53
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 3.53
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 3.51
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 3.45
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 3.43
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 3.42
PRDM1 inhibits proliferation of human colon cancer organoids 3.41
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 3.39
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 3.38
Ribosome profiling upon inhibition of eIF4A 3.38
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 3.38
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 3.31
N6-methyladenine DNA Modification in Glioblastoma 3.3
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 3.3
Gene expression signatures of innate lymphoid cells from human blood 3.25
The MEF2B Regulatory Network 3.22
The MEF2B Regulatory Network - RNA-seq data 3.22
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 3.22
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 3.22
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 3.17
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 3.17
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 3.14
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 3.13
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 3.08
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 3.06
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 3.06
SLAM-seq for K562 endogenous mRNA decay 3.05
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 3.04
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 3.04
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 3.04
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 3.02
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 3.01
NR2F2 study 3.01
RNA-seq data 2.99
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 2.99
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 2.95
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 2.93
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 2.9
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 2.89
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 2.82
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 2.82
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 2.8
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 2.8
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 2.79
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 2.78
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 2.78
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 2.77
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.75
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 2.73
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 2.73
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 2.71
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 2.7
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 2.68
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 2.63
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 2.62
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 2.62
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 2.62
Effect of ILF3 on translation during homeostasis and the antiviral response 2.6
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 2.57
EWSR1 influences alternative splicing through direct and indirect mechanisms 2.57
Transcriptomic analysis of human tonsillar TFH subsets 2.56
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 2.53
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 2.51
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 2.5
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 2.49
Real-time observation of light-controlled transcription in living cells 2.49
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 2.48
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 2.48
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 2.46
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 2.46
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 2.45
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 2.45
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 2.41
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 2.39
ETV7 and interferon response 2.39
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 2.35
Retinoic acid suppresses MYB in adenoid cystic carcinoma 2.26
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 2.26
The transcriptome effect of overexpressing EZH2 in MCF7 2.25
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 2.24
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 2.23
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 2.22
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 2.22
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 2.19
Regulating Interleukin-2 activity with engineered receptor signaling clamps 2.14
Impact on erythroid progenitor type on erythroid differntiation 2.14
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 2.13
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 2.09
RNA-seq analysis upon ARID1B overexpression 2.08
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 2.08
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 2.05
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 2.03
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 2.03
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 2.03
HEK293 TFAM Knockout Expression Study 2.02
Chromatin landscape of human visceral and subcutaneous adipocytes 1.99
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 1.99
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 1.98
Illumina Total RNA-seq in HeLa 1.98
Single-cell analysis of adult human ovary using 10X genomics 1.96
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 1.94
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 1.92
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 1.9
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.84
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 1.83
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 1.79
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 1.77
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 1.76
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 1.75
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 1.73
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 1.71
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 1.71
SF3B1 Degron knockdown RNA-seq 1.69
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.68
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.68
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.68
Functional significance of the HIV-1 Tat signature amino acid residues 1.64
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 1.64
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 1.63
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 1.61
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 1.6
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 1.56
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 1.53
Copper Regulation of HIF-1 Transcription Activity 1.53
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 1.5
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 1.5
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 1.45
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 1.45
Gene expression changes due to PARP knockdown in human cells 1.44
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 1.41
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 1.41
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 1.38
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 1.37
A single-cell transcriptome atlas of the human pancreas 1.37
Transcriptional landscape changes during human embryonic stem cell derivation 1.37
FBXW7 modulates stress response by post-translational modification of HSF1 1.32
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 1.32
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 1.31
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 1.25
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 1.25
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 1.25
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  1.24
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 1.24
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 1.24
Gene expression profile in breast cancer cells 1.24
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 1.21
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 1.17
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 1.16
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 1.14
RNAseq of cell lines with knocked in ESR1 mutations 1.12
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 1.11
An optimization system for isolating and sequencing of single human colon cancer cells 1.08
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 1.07
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 1.07
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 1.03
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.02
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 0.95
Measure transcript integrity using RNA-seq data 0.94
RNA seq with AML (NB4) cells upon FTO inhibition 0.93
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.93
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.88
TT-Seq captures the human transient transcriptome 0.88
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 0.88
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.86
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 0.85
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 0.85
ARS2 is a general suppressor of pervasive transcription [RNAseq] 0.84
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 0.82
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.81
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.81
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.78
Iron response of HepG2 cells 0.78
Metastasis in triple-negative breast cancer 0.73
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 0.73
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 0.68
Gene Expression Profiling of WT and KDM3A Knocked out Cell 0.68
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 0.66
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.64
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.64
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 0.63
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 0.63
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.62
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.6
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 0.57
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.55
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 0.55
Genetic-to-epigenetic Therapy for Pancreatic Cancer 0.52
The circadian transcriptional landscape in primary human mammary epithelial cells 0.52
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 0.49
K562 polyA RNA-Seq 0.48
High-resolution comparative analysis of great ape genomes 0.48
RNA-Seq of PRMT1 overexpression ECA109 cells 0.44
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 0.43
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 0.42
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 0.42
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.41
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.41
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.36
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.36
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.34
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 0.34
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 0.34
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.32
Ribosomal protein RPL26 is the principal target of UFMylation 0.3
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.27
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 0.25
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 0.24
AUF-1 affected genes in human skin cells 0.23
p53 activity results in DNA replication fork processivity 0.22
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 0.21
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.16
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 0.14
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 0.14
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 0.12
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 0.12
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 0.12
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.1
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.1
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 0.08
MARS Seq data from human cortical organoids 0.08
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.06
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 0.06
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.03
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.03
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 0.02
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 0.02
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.02
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation